Clinical trial
Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis
NCT00049751
Study timeline
Study start (unknown)2002-09-01Date precision: month
Registry last updated2006-08-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
AdalimumabDRUG · verified · RxNorm: adalimumab
Sponsors & collaborators
Abbottlead sponsor
Mapped research locations
New YorkNew York, United States1Los AngelesCalifornia, United States1NashvilleTennessee, United States1DenverColorado, United States1New HavenConnecticut, United States1DaytonOhio, United States1BrooklynNew York, United States1FairfaxVirginia, United States1West Palm BeachFlorida, United States1Baton RougeLouisiana, United States1Walnut CreekCalifornia, United States1CantonOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00049751 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.